LPL Financial LLC

Position in PRME — Prime Medicine, Inc.

CIK 1403438 FORT MILL, SC

Back to PRME Full portfolio

Position in PRME

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$340,122

+$108,967 QoQ

Shares Held

92,174

+38.8% QoQ

Ownership

0.051%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#72

of 186 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Derivatives in PRME

reported options exposure · as of Jun 30, 2025

CallValue

$24,700

CallShares

10,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $551,304,275 across 203 Biotechnology names. PRME ranks #114 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	289,111	$143,610,107
2	REGN	Regeneron Pharmaceuticals, Inc.	65,755	$41,000,872
3	ARWR	Arrowhead Pharmaceuticals, Inc.	310,761	$25,330,129
4	ARGX	Argenx SE	19,499	$18,090,587
5	ALNY	Alnylam Pharmaceuticals, Inc.	57,890	$17,426,626
6	HALO	Halozyme Therapeutics, Inc.	203,557	$15,932,406
7	RPRX	Royalty Pharma plc	249,117	$13,967,990
8	INSM	INSMED Inc	128,553	$13,706,320

All Filings in PRME

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$340,122	92,174	+38.8%	Shares	Sole	2026-08-07
2026-03-31	$231,155	66,424	+101.7%	Shares	Sole	2026-05-06
2025-12-31	$114,246	32,924	+6.1%	Shares	Sole	2026-02-11
2025-09-30	$171,956	31,039	—	Shares	Sole	2025-11-12
2025-06-30	$24,700	10,000	0.0%	Call	Sole	2025-08-12
2025-03-31	$19,900	10,000	—	Call	Sole	2025-05-07
No filing history on record for this holder in this stock.